Tarsus Pharmaceuticals, Inc. TARS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

53/100

2/7 Pass

SharesGrow Intrinsic Value

Tarsus Pharmaceuticals, Inc. (TARS) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Vivo Capital IX, LLC 2,469,001 주 보유. 기타 주요 보유자에는 Vivo Capital Fund IX, L.P. 및 RTW INVESTMENTS, LP.

지난 12개월간 내부자는 67 건의 거래를 수행 TARS 주식 — 17 건 매수 (평가액 RSU 보상) 및 33 건 매도 (평가액 $10.07M). 내부자 매도가 매수를 초과했습니다.

TARS 내부자 보유 현황

최대 보유자

Vivo Capital IX, LLC

2,469,001 주

매수 (12개월)

$0.00 평가액

매도 (12개월)

$10.07M 평가액

12개월 거래 활동

매수 25%

매도 49%

내부자 주요 보유자

#	이름	직책	보유 주식수	최종 신고일	상대적 규모
1	Vivo Capital Ix, Llc	10 Percent Owner	2,469,001	2022-05-05	100%
2	Vivo Capital Fund Ix, L.p.	Director	2,469,001	2022-05-05	100%
3	Rtw Investments, Lp	10 Percent Owner	2,013,601	2021-05-07	82%
4	Link William J Phd	Director	116,332	2026-03-18	5%
5	Neervannan Seshadri	Chief Operating Officer	82,791	2026-03-24	3%
6	Wahl Bryan	General Counsel	72,315	2026-03-19	3%
7	Mottiwala Aziz	Chief Commercial Officer	70,250	2026-03-19	3%
8	Azamian Bobak R.	President/ceo and Board Chair	57,052	2026-03-19	2%
9	Farrow Jeffrey S	See Remarks	47,635	2026-03-19	2%
10	Whitfield Dianne C.	Chief Human Resources Officer	43,273	2026-03-19	2%
11	Greenstein Leonard M.	Chief Financial Officer	26,785	2023-04-21	1%
12	Lin Elizabeth Yeu	Chief Medical Officer	24,077	2026-03-19	1%
13	Tester Jason E.	10 Percent Owner	10,000	2021-06-17	0%
14	Ackermann Michael	Director	7,000	2022-07-01	0%
15	Pyott David E I	Director	3,729	2026-02-20	0%
16	Holdbrook Mark J.	V.p., Clinical Affairs	3,389	2023-03-21	0%
17	Crane Rosemary A	Director	3,350	2024-06-14	0%
18	Yarno Wendy L	Director	2,954	2025-06-16	0%
19	Morrison Scott W	Director	2,954	2025-06-16	0%
20	Goldberg Andrew D.	Director	2,954	2025-06-16	0%

최근 거래 (최근 12개월)

날짜	이름	직책	유형	주식수	주가	금액
2026-03-20	Neervannan Seshadri	Chief Operating Officer	정보 매도	2,989	$66.75	$199.52K
2026-03-19	Lin Elizabeth Yeu	Chief Medical Officer	정보 매도	390	$67.00	$26.13K
2026-03-18	Lin Elizabeth Yeu	Chief Medical Officer	정보 매도	379	$68.71	$26.04K
2026-03-17	Lin Elizabeth Yeu	Chief Medical Officer	정보 매도	375	$69.42	$26.03K
2026-03-19	Wahl Bryan	General Counsel	정보 매도	4,231	$67.00	$283.48K
2026-03-18	Wahl Bryan	General Counsel	정보 매도	4,125	$68.71	$283.43K
2026-03-17	Wahl Bryan	General Counsel	정보 매도	4,084	$69.42	$283.51K
2026-03-19	Whitfield Dianne C.	Chief Human Resources Officer	정보 매도	4,174	$67.00	$279.66K
2026-03-18	Whitfield Dianne C.	Chief Human Resources Officer	정보 매도	4,071	$68.71	$279.72K
2026-03-17	Whitfield Dianne C.	Chief Human Resources Officer	정보 매도	4,029	$69.42	$279.69K
2026-03-19	Azamian Bobak R.	President/ceo and Board Chair	정보 매도	11,964	$67.00	$801.59K
2026-03-18	Azamian Bobak R.	President/ceo and Board Chair	정보 매도	11,667	$68.71	$801.64K
2026-03-17	Azamian Bobak R.	President/ceo and Board Chair	정보 매도	10,972	$69.42	$761.68K
2026-03-19	Neervannan Seshadri	Chief Operating Officer	정보 매도	4,589	$67.00	$307.46K
2026-03-18	Neervannan Seshadri	Chief Operating Officer	정보 매도	3,610	$68.71	$248.04K
2026-03-17	Neervannan Seshadri	Chief Operating Officer	정보 매도	3,125	$69.42	$216.94K
2026-03-19	Mottiwala Aziz	Chief Commercial Officer	정보 매도	4,440	$67.00	$297.48K
2026-03-18	Mottiwala Aziz	Chief Commercial Officer	정보 매도	4,330	$68.71	$297.51K
2026-03-17	Mottiwala Aziz	Chief Commercial Officer	정보 매도	4,286	$69.42	$297.53K
2026-03-19	Farrow Jeffrey S	See Remarks	정보 매도	2,186	$67.00	$146.46K
2026-03-18	Farrow Jeffrey S	See Remarks	정보 매도	2,133	$68.71	$146.56K
2026-03-17	Farrow Jeffrey S	See Remarks	정보 매도	2,111	$69.42	$146.55K
2026-03-16	Link William J Phd	Director	정보 매도	493	$69.75	$34.39K
2026-03-15	Lin Elizabeth Yeu	Chief Medical Officer	옵션 행사 (매도)	2,511	-	-
2026-03-15	Wahl Bryan	General Counsel	옵션 행사 (매도)	4,790	-	-